Ali A. Habib

2.5k total citations
48 papers, 345 citations indexed

About

Ali A. Habib is a scholar working on Neurology, Infectious Diseases and Oncology. According to data from OpenAlex, Ali A. Habib has authored 48 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 9 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in Ali A. Habib's work include Myasthenia Gravis and Thymoma (29 papers), Parkinson's Disease and Spinal Disorders (13 papers) and Peripheral Neuropathies and Disorders (11 papers). Ali A. Habib is often cited by papers focused on Myasthenia Gravis and Thymoma (29 papers), Parkinson's Disease and Spinal Disorders (13 papers) and Peripheral Neuropathies and Disorders (11 papers). Ali A. Habib collaborates with scholars based in United States, Italy and Canada. Ali A. Habib's co-authors include Nirusha Lachman, Kevin Christensen, Samuel J. Asirvatham, Hiroshi Mitsumoto, Thomas H. Brannagan, Don Gilden, D. Scott Schmid, Joseph E. Safdieh, Tahseen Mozaffar and Paola Mina‐Osorio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Ali A. Habib

44 papers receiving 333 citations

Peers

Countries citing papers authored by Ali A. Habib

Since Specialization

Citations

This map shows the geographic impact of Ali A. Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali A. Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali A. Habib more than expected).

Fields of papers citing papers by Ali A. Habib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali A. Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali A. Habib. The network helps show where Ali A. Habib may publish in the future.

Co-authorship network of co-authors of Ali A. Habib

This figure shows the co-authorship network connecting the top 25 collaborators of Ali A. Habib. A scholar is included among the top collaborators of Ali A. Habib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali A. Habib. Ali A. Habib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions 2025 ·Journal of Neuromuscular Diseases ·Vera Bril, (unknown), Julian Großkreutz, Ali A. Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, Tuan Vu, (unknown), Bernhard Greve, (unknown), Franz Woltering, (unknown), John Vissing, (unknown)	2
2	Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial 2025 ·The Lancet Neurology ·Ali A. Habib, Chongbo Zhao, Inmaculada Aban, Marcondes C. França, (unknown), Gerd Meyer zu Hörste, Elzbieta Klimiec, Michael Pulley, (unknown), Petranka Krumova, (unknown), Jillian Smith, (unknown), Kathleen Blondeau, (unknown), Gil I. Wolfe, Hiroyuki Murai	10
3	United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use 2024 ·Journal of Neurology ·Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, (unknown), (unknown), Ajeet Gajra, Richard J. Nowak, James F. Howard, (unknown)	6
4	Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study 2024 ·PLoS ONE ·Naoum P. Issa, (unknown), Eric C. Polley, (unknown), (unknown), Sean A. Smith, Ali A. Habib, (unknown), Betty Soliven, Kourosh Rezania	1
5	US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization 2024 ·Drugs - Real World Outcomes ·Richard J. Nowak, Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, (unknown), (unknown), Ajeet Gajra, James F. Howard, (unknown)	1
6	Time to response with ravulizumab, a long‐acting terminal complement inhibitor, in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis 2024 ·European Journal of Neurology ·Ali A. Habib, Michael Benatar, Tuan Vu, Andreas Meisel, Shahram Attarian, Masahisa Katsuno, Serena G. Liao, Kathleen N. Beasley, James F. Howard	4
7	Evaluating the Ergonomic Performance of a Novel Periodontal Curette with Adaptive Handle Design 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Kathryn Osann, Ali A. Habib, Petra Wilder‐Smith	1
8	Effect of a Novel Adaptive Handle Design on the Ergonomic Performance of Periodontal Curettes in Dental Hygienists with and without Musculoskeletal Disorders: A Pilot Clinical Study 2024 ·Dentistry Journal ·(unknown), (unknown), Ali A. Habib, (unknown), (unknown), Petra Wilder‐Smith	1
9	Fixed Cycle and Q2W Dosing of Intravenous Efgartigimod for gMG: Part A of ADAPT NXT 2024 ·Neurology ·(unknown), (unknown), Vera Bril, Ali A. Habib, Kristl G. Claeys, Yessar Hussain, Kelly Gwathmey, Gregory Sahagian, Elena Cortés‐Vicente, Jeffrey T. Guptill, Deborah Gelinas, Anne Sumbul, (unknown), (unknown), (unknown), Renato Mantegazza, Andreas Meisel, Shahram Attarian	1
10	Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies 2023 ·Journal of the Neurological Sciences ·Vera Bril, John Vissing, Artur Drużdż, Julian Großkreutz, Ali A. Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, Tuan Vu, (unknown), Bernhard Greve, Franz Woltering, (unknown)	1
11	Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials 2023 ·Neurology ·Jeffrey T. Guptill, Michael Benatar, Volkan Granit, Ali A. Habib, James F. Howard, (unknown), Richard J. Nowak, Ik Jae Lee, Katherine Ruzhansky, Mazen M. Dimachkie, Gary Cutter, Henry J. Kaminski	15
12	Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO 2023 ·Neurology and Therapy ·Antoine Regnault, Thomas Morel, Christine de la Loge, (unknown), Henry J. Kaminski, Ali A. Habib	12
13	Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs 2023 ·Frontiers in Public Health ·(unknown), (unknown), Ali A. Habib, (unknown), (unknown), (unknown), Cecilia Zvosec, (unknown), Mai Sato, (unknown), (unknown)	4
14	Safety and outcomes with efgartigimod use for acetylcholine receptor‐positive generalized myasthenia gravis in clinical practice 2023 ·Muscle & Nerve ·Nakul Katyal, (unknown), Raghav Govindarajan, Perry B. Shieh, Suraj Muley, (unknown), (unknown), (unknown), (unknown), Manisha Kak Korb, Namita Goyal, Tahseen Mozaffar, Neelam Goyal, Ali A. Habib, Srikanth Muppidi	18
15	Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis (P1-5.003) 2023 ·Neurology ·(unknown), (unknown), Raj Bandaru, Anusorn Thanataveerat, Matthew Kent, Michael K. Hehir, Ali A. Habib	2
16	A Novel Ergonomic Curette Design Reduces Dental Prophylaxis-Induced Muscle Work and Fatigue 2023 ·Dentistry Journal ·(unknown), (unknown), (unknown), Kathryn Osann, Ali A. Habib, (unknown), Petra Wilder‐Smith	4
17	Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease 2023 ·Transfusion Medicine Reviews ·Paola Mina‐Osorio, Minh‐Ha Tran, Ali A. Habib	11
18	Emerging drugs for amyotrophic lateral sclerosis 2011 ·Expert Opinion on Emerging Drugs ·Ali A. Habib, Hiroshi Mitsumoto	35
19	Therapeutic Strategies for Diabetic Neuropathy 2010 ·Current Neurology and Neuroscience Reports ·Ali A. Habib, Thomas H. Brannagan	34
20	Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman 2009 ·Journal of NeuroVirology ·Ali A. Habib, Don Gilden, D. Scott Schmid, Joseph E. Safdieh	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact